AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Shares Down 1.4% – Should You Sell?

Shares of AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report) dropped 1.4% during mid-day trading on Tuesday . The stock traded as low as $11.91 and last traded at $11.91. 821,451 shares changed hands during mid-day trading, a decline of 1% from the average daily volume of 831,496 shares. The stock had previously closed at $12.08.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 1.4%

The stock has a market cap of $300.13 million, a PE ratio of 17.67 and a beta of -0.64. The business has a 50 day moving average price of $11.70 and a 200 day moving average price of $12.76.

Institutional Investors Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Hedge funds and other institutional investors have recently made changes to their positions in the company. J.Safra Asset Management Corp raised its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 10.0% during the 4th quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock worth $117,000 after buying an additional 741 shares during the period. CoreCap Advisors LLC acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter valued at $36,000. Triumph Capital Management purchased a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the 3rd quarter worth $70,000. Worth Asset Management LLC increased its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% in the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after acquiring an additional 5,190 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after acquiring an additional 10,146 shares during the period.

AGF U.S. Market Neutral Anti-Beta Fund Company Profile

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

See Also

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.